Biotech Values

[pcrutch]

I always enjoy Alex's pieces, more so than any other biotech analyst. But yeah, he tends to use hyperbole a lot to get his point across.

Here I think he is somewhat right with his use of it because of how low CLDX's market cap is relative to the opportunity. Not saying it'll be huge like him, but $250mcap seems pretty low to me.